Alik Farber, MD

ISET 2024

Management of CLTI in an Era of BEST-CLI and BASIL-2

02/13/2024

Dr. Alik Farber discusses his ISET 2024 presentation on the BEST-CLI and BASIL-2 trials and how to best manage patients with CLTI in the wake of these trials.

Dr. Alik Farber discusses his...

02/13/2024

Vascular Disease Management

An Update on the BEST-CLI Trial

07/12/2017

Alik Farber , MD;

The BEST-CLI trial is a timely and critically needed trial that will significantly impact clinical practice by defining an evidence-based standard of care for patients with critical limb ischemia.

The BEST-CLI trial is a timely...

07/12/2017

Vascular Disease Management

Clinical Trial Update

Discussing the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial

01/03/2023

Alik Farber , MD;

Matthew Menard , MD;

Kenneth Rosenfield , MD, MHCDS;

Both surgical bypass and endovascular revascularization are considered standard-of-care treatment for patients with chronic limb-threatening ischemia (CLTI), but it has remained largely unknown which treatment approach leads to better...

Both surgical bypass and...

01/03/2023

Cath Lab Digest